Autopsy report · NCT00180830
Glivec Phase II Pediatric Study
Cause of deathNo reason given
Life of this trial
- Registered 1 year 9 months after it had already started.
- 36 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Sponsor type
- University, hospital or other
- Conditions
- Cancer
- Interventions
- Glivec; Gleevec
- Participants
- 36
- Sites
- 3
- Countries
- France, Netherlands, United Kingdom
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.